Icon
+91 94997 68112
Login Register

KAZANO - (12.5mg; 500mg/1gm, Tablet, Oral)

ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE Takeda
12.5mg; 500mg/1gm, Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
None None
Used to improve blood sugar (glucose) control in adults with type 2 diabetes.
Yes
******* ** **** ** ****** ** ****** *** ****** **** **** ******** ******®, ******®, *** *****® **** *** ********** ******* *** ********** ******** ** *********** ** ********* ************* *** ************ ************* ************. *** ****** ******* *** ********* **** ** ************* *** ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****) ** ******* *** ** *********. *** ** ****** **** ****** ** ***. ****. ******* ****** ******** **** ***** **** ** **** **** ******* ** ******* *** ****** *** *** ************ *********. ******* *** *** **** **** ***** * **** ** ***, **** **** *** *********. ******* *** *** **** ***** * **** *** ** ****** '*** (**** **, ****). ********* **** ***'* ****** ****** **** ****. *****, ***** ***** ** ***** ** ********* *** ******* ******* *** ****** ******** **** **** ********* ****** ******* (**** **, ****). *********, *** **** ** ******** *** *** ** ******* **** *** **** ** *** ********** ** *.*. ****** **. ******* (*.* ***** **** ****).
KAZANO Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
******* **** *** **** *** **** *** **** ** ** *** ** ******* ******* *******
****** ******** ******* ******* ******* **** ** ** *** ** ******* ******* *******
******* **** *** **** *** **** *** **** *** **** *** **** *** *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** *** *, **** ********* **** ** ** *** ** ********* ******** ***** **** ****
****** ******** ** \ ** **** *, **** ********* **** ** ** *** ** **** ***** **** ****
******* ** \ ** *** ********* *** ********* ********* ******** ** **** ****
  1. *** **, **** : ******* ******** ****** ********* *** **** ** ******* ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****) ** *******.
  2. *** *, **** : ****** **** ******* ** ** ** **.
  3. *** *, **** : ****** ******** ******** ****** ***** *** **** ** **** ******* ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****) ** *******.
  4. *** *, **** : ****** ***** * **** ******* ****** ******** ** ******** ***** ** **.
  5. *** *, **** : ********** ********* **** ******* ** ****** '*** (*** **, ****)
  6. *** **, **** : *** **** *** ********* ********. *****://***.**********.***.***/**********_****/*********/****/********************.***
  7. *** *, **** : ***** ***** ** ***** ** ********* *** ******* ******* *** ****** ******** **** ****** '*** *** ***** *** **** ********* ****** ******* (**** **, ****).
  8. *** **, **** : *** ** **** ***** ********* ** *** ***** **** ******* *** ****** *** ****** ******* ***** ********** ** ****** ******* (**** **, ****)
  9. *** *, **** : ******* ******** ** **
  10. *** **, **** : ****** ******** ** **
  11. *** **, **** : ******* *** ****** **** ** **.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.